Is Marksans Pharma an Indian company?

Is Marksans Pharma an Indian company?

Marksans Pharma Ltd. is an Indian pharmaceutical company having a global footprint.

Who owns marksans Pharma?

Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company.

Is marksans Pharma Glenmark company?

Marksans Pharma, incorporated in 1992, was a wholly–owned subsidiary of Glenmark Pharmaceuticals. It became a separate entity in March 2003 and the name was changed to Marksans Pharma in 2005. Currently the company has presence in Active Pharmaceuticals Ingredients (APIs), formulations and biopharmaceuticals.

What are marksans pharma products?

Gincoplex Pharmaceutical Medicine.

  • Carfin Suspension.
  • Haematinic Syrup.
  • Apresoline Injection.
  • Ripro DSR Capsules.
  • Where is marksans Pharma located?

    Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies.

    Is marksans Pharma a good company?

    Good work environment and culture. Teammates are supportive and management is transparent. Company policies are not good . Appraisal reting is required company policies, not your work see.

    Is marksans Pharma a good stock?

    1. Is Marksans Pharma Ltd a good quality company? Past 10 year’s financial track record analysis by Moneyworks4me indicates that Marksans Pharma Ltd is a average quality company.

    Who is the No 1 Medicine company in India?

    List Of Top 10 Pharmaceutical Companies in India 2020….1. Sun Pharmaceutical Industries Ltd.

    Founder Dilip Shanghvi
    Founded 1983, Vapi
    Headquarters Goregaon, Mumbai
    Revenue 30,091.4 crores INR (US$4.2 billion, 2019)
    Number of employees 32,000 (2019)

    Will marksans increase share price?

    Marksans Pharma Ltd . quote is equal to 46.100 INR at 2022-05-11. Based on our forecasts, a long-term increase is expected, the “Marksans Pharma Ltd” stock price prognosis for 2027-05-07 is 138.446 INR. With a 5-year investment, the revenue is expected to be around +200.32%.

    What is the target of Marksans Pharma?

    MARKSANS Share Price

    4th UP TARGET 86.37
    2nd UP TARGET 69.47
    1st UP TARGET 63.01
    1st DOWN TARGET 44.59
    2nd DOWN TARGET 38.13